• Home »
  • Health Technology »
  • Cardiopad: Africa’s first medical tablet sending results via a mobile-phone connection wins 2014 Rolex Awards for Enterprise
Cardiopad: Africa’s first medical tablet sending results via a mobile-phone connection wins 2014 Rolex Awards for Enterprise

Cardiopad: Africa’s first medical tablet sending results via a mobile-phone connection wins 2014 Rolex Awards for Enterprise

 Five young visionaries from Africa, India, Europe and the Middle East were announced today at London’s leading scientific institution, the Royal Society, as winners of the 2014 Rolex Awards for Enterprise (http://www.rolexawards.com).This year’s Young Laureates – aged 30 and under – impress by both their leadership qualities and in their ability to harness technology in an original way to improve the well-being of the community and the environment, as well as to advance scientific knowledge.

The five Young Laureates were chosen by an international Jury of eight eminent experts who reviewed a shortlist from among 1,800 applicants from all over the world.

Neeti Kailas, 29, India – aims to vastly increase screening of newborn babies for hearing loss, through an inexpensive, easy-to-use device, and to set up an associated network of health-care professionals in India who can diagnose or treat deafness.

Olivier Nsengimana, 30, Rwanda – is promoting breeding programmes and the release of Rwanda’s captive, endangered grey crowned-cranes. The iconic bird, a symbol of wealth and longevity in Rwanda, is a victim of its own beauty, and is often kept as a pet.

Francesco Sauro, 29, Italy – is exploring the vast quartzite caves of South America’s fabled tabletop mountains on the border of Venezuela and Brazil, making discoveries of unique worlds that have evolved in isolation over millennia.

Arthur Zang, 26, Cameroon – has invented what is believed to be Africa’s first medical tablet, which will allow health-care workers in rural areas to send the results of cardiac tests to heart specialists via a mobile-phone connection.

We suggest you read  Africa: Secrets to a successful mHealth campaign

Hosam Zowawi, 29, Saudi Arabia – is developing rapid tests to detect the presence of antibiotic resistant bacteria, now considered a global threat to human health. He also plans a regional public campaign warning of the dangers of the overuse and misuse of antibiotics.



The tablet has the following functionality:

- Performs electrocardiogram (EKG) on patients (acquires the EKG signal that comes from the patient, digitizes, treats and posts it, then prints an exam report.

- Transmits the EKG results to remote cardiologists through the GSM network

- Presents a user-friendly and appropriate interface to the cardiologist, brings elements that can help in the diagnostics and presents information to the cardiologist through a user-friendly Human Machine Interface (HMI).

- Stores EKG exam information and manages notifications: The CardioPad is able to store information linked to EKG exams in an SQL Compact server database, and sends and receives notifications to the cardiologist across the GSM network informing him/her, as well as a new consultation to be interpreted.

- Remote followup and monitoring

Unlike other available medical technologies, the Cardiopad tablet enables doctors to conduct heart examinations like the Electrocardiogram (ECG) to very remote and rural locations. It does this by enabling the results of medical test to be transferred electronically to doctors who will then be able to conduct diagnosis and recommend various treatment methods. This is very useful in very remote areas of Cameroon where patients have to travel for miles to reach the nearest health facility which are usually in urban areas. It not only cuts down on the time and energy spent by rural patients to reach the health facilities it also brings the health practitioners closer to the people remotely.

We suggest you read  How Technology Can Improve the Prognosis for Health Care in Africa



It is the first full touch screen tablet meant for medical use, that has been made in Cameroon and Africa in general. It has the potential of saving many lives and Zang says that the tablet is 97.5 percent reliable. What motivated Mr. Zang to create the tablet was to enable patients with heart diseases from remote parts of Africa be able to get diagnosis of the condition in time and thus seek the treatment required in the early stages of the heart disease or complication. There have been several tests that have been carried out using the tablet and it gave impressive performance which lead to its validation by the Cameroonian Scientific community.